In our previous studies with triple-negative breast cancer (TNBC) cells, such as MDA-MD-231, EMT-6, and 4T1 cells, we did not see an inhibitory effect of fascin inhibitors on the growth of these cells in culture and the growth of primary tumors in animal models [18,19]. This evidence concerns the gene FSCN1 and triple-negative breast carcinoma.